161 related articles for article (PubMed ID: 23553296)
1. Axonal loss in murine peripheral nerves following exposure to recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge.
Margolis DS; Wu EW; Truchan LM
J Bone Joint Surg Am; 2013 Apr; 95(7):611-9. PubMed ID: 23553296
[TBL] [Abstract][Full Text] [Related]
2. Comparing ectopic bone growth induced by rhBMP-2 on an absorbable collagen sponge in rat and rabbit models.
Hsu HP; Zanella JM; Peckham SM; Spector M
J Orthop Res; 2006 Aug; 24(8):1660-9. PubMed ID: 16779816
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effects of recombinant human bone morphogenetic protein-2 on pain-associated behaviors in a rat model following implantation near the sciatic nerve.
Zanella JM; Waleh N; Orduña J; Montenegro J; Paulin J; McKay WF; Wilsey J
J Neurosurg Spine; 2016 Aug; 25(2):154-64. PubMed ID: 26989976
[TBL] [Abstract][Full Text] [Related]
4. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2-mediated pain and inflammation in a rat model of posterolateral arthrodesis.
Mitchell K; Shah JP; Dalgard CL; Tsytsikova LV; Tipton AC; Dmitriev AE; Symes AJ
BMC Neurosci; 2016 Dec; 17(1):80. PubMed ID: 27905881
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model.
Bae HW; Zhao L; Kanim LE; Wong P; Marshall D; Delamarter RB
J Bone Joint Surg Am; 2013 Feb; 95(4):338-47. PubMed ID: 23426768
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
[TBL] [Abstract][Full Text] [Related]
9. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer.
Molina CA; Sarabia-Estrada R; Gokaslan ZL; Witham TF; Bydon A; Wolinsky JP; Sciubba DM
J Neurosurg Spine; 2012 Apr; 16(4):365-72. PubMed ID: 22264176
[TBL] [Abstract][Full Text] [Related]
10. Can a low dosage of recombinant human bone morphogenetic protein-2 loaded on collagen sponge induce ectopic bone?
Alruwaili MK; Sugaya T; Morimoto Y; Nakanishi K; Akasaka T; Yoshida Y
Dent Mater J; 2023 May; 42(3):433-440. PubMed ID: 37032102
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model.
Welch RD; Jones AL; Bucholz RW; Reinert CM; Tjia JS; Pierce WA; Wozney JM; Li XJ
J Bone Miner Res; 1998 Sep; 13(9):1483-90. PubMed ID: 9738522
[TBL] [Abstract][Full Text] [Related]
12. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
13. Characterization of absorbable collagen sponges as rhBMP-2 carriers.
Friess W; Uludag H; Foskett S; Biron R; Sargeant C
Int J Pharm; 1999 Sep; 187(1):91-9. PubMed ID: 10502616
[TBL] [Abstract][Full Text] [Related]
14. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
[TBL] [Abstract][Full Text] [Related]
15. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
[TBL] [Abstract][Full Text] [Related]
16. Maxillary sinus augmentation using recombinant bone morphogenetic protein-2/acellular collagen sponge in combination with a mineralized bone replacement graft: a report of three cases.
Tarnow DP; Wallace SS; Testori T; Froum SJ; Motroni A; Prasad HS
Int J Periodontics Restorative Dent; 2010 Apr; 30(2):139-49. PubMed ID: 20228973
[TBL] [Abstract][Full Text] [Related]
17. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
18. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.
Blumenthal NM; Koh-Kunst G; Alves ME; Miranda D; Sorensen RG; Wozney JM; Wikesjö UM
J Periodontol; 2002 Dec; 73(12):1494-506. PubMed ID: 12546100
[TBL] [Abstract][Full Text] [Related]
19. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue.
Patel VV; Zhao L; Wong P; Kanim L; Bae HW; Pradhan BB; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(11):1201-6. PubMed ID: 16688032
[TBL] [Abstract][Full Text] [Related]
20. Bone Recuperation After rhBMP-2 Insertion in Alcoholic Animals-Experimental Study.
dos S Kotake BG; Salzedas LM; Ervolino E; Calzzani RA; Sebald W; Issa JP
Curr Pharm Des; 2015; 21(24):3557-64. PubMed ID: 25925228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]